Our
geographic spread
MARKET OVERVIEW
The South African private pharmaceutical market, as measured by IMS MAT June 2016, is worth R35,5 billion, with 6,7 % value and 0,4% volume growth.
Adcock Ingram holds a market share of 9,0% in value and 21,4% in volume. Our operations are spread throughout the African continent but our manufacturing facilities are based in South Africa and India The head office for the Group is located in Midrand, South Africa.
![]() |
The tablet and capsule facility located in Wadeville is focused, amongst others, on the manufacturing of anti-retroviral medicines. The Critical Care facility situated in Aeroton produces intravenous fluids, blood bags, renal dialysis products and small-volume parenterals.
|
| Over the Counter focuses on brands sold predominantly in the pharmacy market, where the pharmacist plays a role in the product choice and includes brands like Corenza and Citro-Soda. |
The Prescription portfolio comprises products prescribed by medical practitioners and includes a range of quality and affordable generic medicines. | The Hospital portfolio has a long history in the Group based on an agreement with Baxter which positions Adcock Ingram as a leading supplier of critical care products, including intravenous solutions, blood collection products and renal dialysis systems. | Consumer competes in the Fast Moving Consumer Goods (FMCG) space and includes market-leading brands such as Panado and Bioplus. |






